Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Safety of E2/DRSP vs E2/NETA in Postmenopause
NCT00522873Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of drospirenone, estradiol in postmenopause, sponsored by Bayer. Started Aug 2007; status: completed.
02
Drugs
drospirenoneestradiol
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT00522873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522873.